D
Denali Therapeutics Inc.
DNLI · NASDAQ · Healthcare · 3.9B
Closing price
$19.45
+4.18% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
3.4×
Enterprise value / EBITDAEV/EBITDA
-6.5×
Free cash flow yieldFCF yield
-12.4%
Return on equityROE
-50.6%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.